Diabetic neuropathy prevention may take more than lower A1C. Discover what new research reveals about glucose control and nerve damage risk.
Read More »Can Better Self-Management Protect the Kidneys Before Damage Takes Hold?
Can better diabetes self-management protect kidney health? Explore new trial findings on A1C, blood pressure, cholesterol, and kidney function.
Read More »Does Every Person With Type 1 Diabetes Really Need a Foot Exam Every Year?
Discover what the OPTI-ONE study reveals about type 1 diabetes foot screening, annual exams, and whether low-risk patients need fewer visits.
Read More »Lose 5% Now, Benefit Decades Later? Prediabetes Data Point to a Possible Legacy Effect
A 34-year study links early weight loss in prediabetes to lower cardiovascular risks. Explore the findings and what they mean for prevention.
Read More »Diabetes Hospitalizations Aren’t Just About Heart and Kidney Disease Anymore
Explore why diabetes hospitalizations involve more than heart and kidney disease, including infections, respiratory illness, and mental health.
Read More »Quit Smoking, Protect More Than Your Heart: When Diabetes Complication Risk Starts to Fall
New research links smoking cessation to lower diabetes complication risks. Explore what the findings mean for kidney, eye, and nerve health.
Read More »Your Genes Aren’t Your Destiny: Can Lifestyle Still Move the Needle on Diabetes Risk?
Genetic risk for type 2 diabetes may be inherited, but new research suggests diet, exercise, and sleep can still help lower overall risk.
Read More »378 Trials, 113,000+ Participants: What Actually Works to Stop Prediabetes From Becoming Diabetes?
Discover what 378 trials involving 113,000+ participants reveal about prediabetes treatment, lifestyle changes, metformin, and incretin therapies.
Read More »Prediabetes Isn’t One-Size-Fits-All: Why the Same Exercise Plan Gets Different Results
New research shows the prediabetes exercise response may differ by glucose phenotype, highlighting the potential for more personalized prevention plans.
Read More »Teplizumab Has Competition: A Head-to-Head Trial Could Reshape Type 1 Diabetes Prevention
TrialNet’s ASCEND T1D trial compares ATG with teplizumab to explore new ways to delay progression of Stage 2 type 1 diabetes.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.